Neurotar reaches the break even point at the end of 2012

Neurotar’s sales increased by a factor of 10 in 2012 compared to 2011.  Sales revenues come mostly from service provision to companies located outside of Finland.  Two of Neurotar’s clients are top ten pharmaceutical companies.  Approximately one quarter of revenues comes from cosmetics.